# Beida Biomedical Industry Fund

> Beida Biomedical Industry Fund is a VC fund backing Health Care and Clinical Trials. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 4
- Last investment: Apr 2021
- Lead investor: 25%
- Last updated: Aug 2026

Beida Biomedical Industry Fund is an investment fund.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 50% |
| Clinical Trials | 2 | 50% |
| Medical | 1 | 25% |
| Biotechnology | 1 | 25% |
| Pharmaceutical | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 25% |
| Series C | 1 | 25% |
| Series D | 1 | 25% |
| Funding Round | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| VivaVision Biotech | VivaVision Biotech is a clinical-stage R&D biopharmaceutical company. | $46.2M | Series D | Apr 21, 2021 |  |
| Clover Biopharmaceuticals | Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases. Clover is utilizing its proprietary Trimer-Tag© technology platform to develop novel biologics targetingtrimerization-dependent pathways. Additionally, Clover is leveraging its in-house cGMP biomanufacturing capabilities to develop select biosimilars. | $43.1M | Series B | Nov 27, 2019 |  |
| VivaVision Biotech | VivaVision Biotech is a clinical-stage R&D biopharmaceutical company. | $9.2M | Series C | Sep 26, 2019 |  |
| Viva Biotech | Viva Biotech is a Healthcare Start Up Based In Shanghai. | $30M |  | Jun 21, 2018 |  |

4 of 4 investments shown.

## Co-investors
- [JMCR Partners](https://shizune.co/investors/profile/jmcr-partners) — VC Fund, 2 deals together
- [Ming Bioventures](https://shizune.co/investors/profile/ming-bioventures) — VC Fund, 2 deals together
- [Viva Ventures Biotech Fund](https://shizune.co/investors/profile/viva-ventures-biotech-group) — VC Fund, 2 deals together
- [Xiamen Changrong Investment Management](https://shizune.co/investors/profile/xiamen-changrong-investment-management) — VC Fund, 2 deals together
- Yingqi Investment — VC Fund, 2 deals together
- [Cenova Capital](https://shizune.co/investors/profile/cenova-capital-215e) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Beida Biomedical Industry Fund invest in?

Beida Biomedical Industry Fund invests primarily in Health Care, Clinical Trials and Medical startups, most often at Series B and Series C stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Beida Biomedical Industry Fund last invest?

The most recent investment recorded for Beida Biomedical Industry Fund closed in Apr 2021. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co